首頁 > 市場調查報告書 > 製藥

消化器

市場調查報告書

商品編碼

1392116

肛裂治療市場：依治療類型、給藥途徑、配銷通路及地區

Anal Fissure Treatment Market, By Treatment Type, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2023年11月22日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2023年全球肛裂治療市場規模為10.393億美元，預計2030年將達14.919億美元，2023年至2030年複合年成長率為5.3%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	10.393 億美元
實績資料	2018-2021	預測期	2023-2030
預測期複合年成長率	5.30%	2030年市場規模預測	14.919 億美元

圖 1. 2023 年肛裂治療的全球市場佔有率（依地區分類）

肛裂是一種常見的疾病，影響著世界各地的許多人。肛門黏膜出現小撕裂或割傷，引起不適、疼痛，有時還會在排便時出血。儘管肛裂可能會自行癒合，但通常需要治療來緩解症狀並促進癒合。

大多數肛裂會在幾週內自行癒合，但如果不癒合可能會出現併發症。這些被稱為慢性肛裂。肛裂非但沒有癒合，反而重複惡性循環，疤痕持續存在。

肛裂的症狀包括排便時疼痛、排便後疼痛持續數小時、排便後大便或衛生紙上有鮮紅色血、肛門周圍皮膚可見裂紋以及肛裂周圍皮膚。這可能包括小腫塊或皮贅。

由於全球肛裂盛行率不斷上升，全球肛裂治療市場正在顯著成長。久坐的生活方式、不良的飲食習慣和人口高齡化等因素導致肛裂發生率增加。人們對各種治療方案的可用性的認知不斷提高，以及對微創手術的需求不斷增加，進一步推動了市場的成長。

市場動態：

全球肛裂盛行率的增加和市場參與企業不斷推出的產品預計將在預測期內推動市場成長。例如，根據臨床醫學2022年9月15日發布的資料，新墨西哥州一般人群肛裂的年發生率為0.11%。

本研究的主要特點

本研究對全球肛裂治療市場進行了全面分析，包括以 2022 年為基準年的 2023 年至 2030 年預測期內的市場規模和複合年成長率。
該報告闡明了各個區隔市場的潛在商機，並為該市場提供了一系列有吸引力的投資提案。
本報告提供了有關市場促進因素、抑制因素因素、機會、新產品發布和核准、市場趨勢和促進因素、區域前景、主要企業採取的競爭策略等的重要考察。
全球肛裂治療市場主要企業的簡介，重點介紹公司背景、產品系列、財務實績、策略等。
這項研究的主要企業包括Abbie、諾華、Teva Pharmaceuticals、Troikaa、RDD Pharma, Ltd、Kyowa Kirin Co., Ltd.、Cipla Inc.、Ipsen Pharma、Sanofi、Boehringer Ingelheim International GmbH、Bliss GVS、SRS Life Sciences 、健康類包括Life Pharma Private Limited、Geri-Care Pharmaceuticals Corp.等。
該報告的見解使公司行銷人員和負責人能夠就產品發布、市場擴張和行銷策略做出資訊的決策。
全球肛裂治療市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球肛裂治療市場的各種策略矩陣做出資訊的決策。

介紹
北美洲
美國
加拿大
歐洲
英國
德國
法國
義大利
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
日本
印度
澳洲
韓國
東南亞國協
其他亞太地區
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲
中東
海灣合作理事會國家
以色列
其他中東地區
非洲
南非
北非
中部非洲

第9章競爭形勢

Abbvie
Novartis AG
Teva Pharmaceuticals
Troikaa
RDD Pharma, Ltd
Kyowa Kirin Co., Ltd
Cipla Inc.
Ipsen Pharma
Sanofi
Boehringer Ingelheim International GmbH
Bliss GVS
SRS Life Sciences
Healthy Life Pharma Private Limited
Geri-Care Pharmaceuticals Corp

第10章

調查方法
關於出版商

簡介目錄

Product Code: CMI6358

Global Anal Fissure Treatment Market is estimated to be valued at US$ 1,039.3 Mn in 2023, and is expected to reach US$ 1,491.9 Mn by 2030, exhibiting a compound annual growth rate (CAGR) of 5.3% from 2023 to 2030.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 1,039.3 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	5.30%	2030 Value Projection:	US$ 1,491.9 Mn

Figure 1. Global Anal Fissure Treatment Market Share (%), By Region, 2023

Anal fissure is a common medical condition that affects a significant number of individuals worldwide. It refers to a small tear or cut in the lining of the anus, resulting in discomfort, pain, and sometimes bleeding during bowel movements. While anal fissures can heal on their own, it often require treatment to alleviate symptoms and promote healing.

Many anal fissures heal by themselves in a few weeks, but complications can develop when they don't. These are called chronic anal fissures. Instead of healing, they continue to reinforce themselves in a vicious cycle, leaving a persistent wound.

Symptoms of anal fissure includes; Pain during bowel movements, Pain after bowel movements that can last up to several hours, Bright red blood on the stool or toilet paper after a bowel movement, a visible crack in the skin around the anus, a small lump or skin tag on the skin near the anal fissure

Global anal fissure treatment market is witnessing significant growth due to increasing prevalence of anal fissures globally. Factors such as sedentary lifestyles, poor dietary habits, and rising aging population contribute to growing incidence of anal fissures. Rising awareness about the availability of various treatment options and increasing demand for minimally invasive procedures are further driving the market growth.

Market Dynamics:

Increasing prevalence of anal fissure globally and increasing product launches by the market players are expected to aid drive the market growth over the forecast period. For instance, on September 15, 2022, according to the data published by the Clinical Medicine, annual incidence of anal fissures in the general population is 0.11% in New Mexico.

Key Features of the Study:

This study provides a comprehensive analysis of the global anal fissure treatment market, including market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period of 2023-2030, with 2022 as the base year
The report elucidates potential revenue opportunities across different segments and offers attractive investment proposition matrices for this market
It provides key insights into market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
The profiles of key players in the global anal fissure treatment market are included, highlighting their company background, product portfolio, financial performance, and strategies
Key companies covered in this study include Abvie, Novartis AG, Teva Pharmaceuticals, Troikaa, RDD Pharma, Ltd, Kyowa Kirin Co., Ltd, Cipla Inc., Ipsen Pharma, Sanofi, Boehringer Ingelheim International GmbH, Bliss GVS, SRS Life Sciences, Healthy Life Pharma Private Limited, and Geri-Care Pharmaceuticals Corp
The insights from this report enable marketers and management authorities of companies to make informed decisions regarding product launches, market expansion, and marketing tactics
Global anal fissure treatment market report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders can make informed decisions through different strategy matrices used in analyzing the global anal fissure treatment market

Anal Fissure Treatment Market Detailed Segmentation:

By Treatment Type
- Laxatives
- Topical Nitrates
- Calcium Channel Blockers
- Stool Softeners
- Surgery
- Others
By Route of Administration
- Oral
- Topical
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Top companies in Global Anal Fissure Treatment Market
- Abvie
- Novartis AG
- Teva Pharmaceuticals
- Troikaa
- RDD Pharma, Ltd
- Kyowa Kirin Co., Ltd
- Cipla Inc.
- Ipsen Pharma
- Sanofi
- Boehringer Ingelheim International GmbH.
- Bliss GVS
- SRS Life Sciences
- Healthy Life Pharma Private Limited
- Geri-Care Pharmaceuticals Corp.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Anal Fissure Treatment Market, By Treatment Type
- Anal Fissure Treatment Market, By Route of Administration
- Anal Fissure Treatment Market, By Distribution Channel
- Anal Fissure Treatment Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing Prevalence of Anal Fissures
Rising Awareness and Removing Social Stigma
- Restraints
Social Taboo Inhibiting Treatment Seeking
Product Recall
- Opportunities
Huge Scope in Emerging Economies
Growing Demand for Minimally Invasive Procedures
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Anal Fissure Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Anal Fissure Treatment Market, By Treatment Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Laxatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Topical Nitrates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Calcium Channel Blockers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Stool Softeners
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

6. Global Anal Fissure Treatment Market, By Route of Administration, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Global Anal Fissure Treatment Market, By Distribution Channel, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

8. Global Anal Fissure Treatment Market, By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
China
Japan
India
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Mn)
South Africa
North Africa
Central Africa

9. Competitive Landscape

Abbvie
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
Teva Pharmaceuticals
Troikaa
RDD Pharma, Ltd
Kyowa Kirin Co., Ltd
Cipla Inc.
Ipsen Pharma
Sanofi
Boehringer Ingelheim International GmbH
Bliss GVS
SRS Life Sciences
Healthy Life Pharma Private Limited
Geri-Care Pharmaceuticals Corp
Analyst Views